DEC 16, 2020 7:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

The Impact of MBT Sepsityper®: The Lahey Experience

Sponsored by: Bruker Daltonics
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Senior Technologist II, Microbiology Laboratory Lahey Hospital & Medical Center, Burlington, MA
    Biography
      Felicia obtained a Graduate Certificate in Health Service Administration from the University of Lowell, as well as a Bachelor’s degree from Northeastern University. She has been employed by Lahey Hospital & Medical Center for the past 29 years, in the Microbiology department. Felicia’s current role and responsibilities as Sr. Tech II include the operations of the Bruker MALDI Biotyper® and the MicroScan WalkAway system. The microbiology laboratory at Lahey implemented the Bruker MALDI Biotyper® in 2015, where Felicia has played a key role in the implementation, acceptance and expansion beyond microbial identification direct from overnight positive blood culture. Additional roles and responsibilities include IQCP and QA processes, creating antibiograms, participating in infection control and antibiotic subcommittee meetings, submit CAP surveys, and implement new technologies. Felicia is also currently an inspector for the College of American Pathologists and received a safety award for 2019 calendar year. In 2019 she was a speaker at the Bruker Customer Symposium at ASM in June, and presented as well in the fall at a local microbiology meeting.

    Abstract
    Date:  December 16, 2020
    Time: 7:00am (PST), 10:00am (EST)
     
    During this webinar we will discuss the implementation and impact of the MALDI Biotyper® and the MBT Sepsityper® in the clinical microbiology laboratory at Lahey Hospital and Medical Center. We will learn how the implementation of the MBT Sepsityper® rapid sample preparation impacts time-to-result in the identification of organisms directly isolated from positive blood cultures. The components of the MBT Sepsityper® kit will be explained as well as the length of time needed to identify organisms using both rapid and non-rapid sample preparations. Case studies will illustrate the critical time-to-identification for targeted antimicrobial treatment. The webinar will close with a Q & A session.
     
    Learning Objectives
    • Learn about the benefits of MALDI-TOF technology over traditional microbiology identification methods
    • Understand the difference in workflow and time-to-result between non-rapid and rapid MBT Sepsityper® sample preparation methods
    • How can the MBT Sepsityper® solution affect the treatment of a patient, especially after implementing the rapid sample preparation method

     

    *Lahey Hospital and Medical Center have validated all described non-IVD methods, software, kits and workflows for in-house clinical use.

    FDA clearance for Bruker´s MBT Sepsityper® Kit US IVD is pending.

     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    Loading Comments...
    Show Resources
    Event Countdown
    • 0 Days
    • 0 Hours
    • 0 Minutes
    • 0 Seconds
    Attendees
    • See more